Andreas Halvorsen - Viking Global Investors
Holding/activity history for Viking Therapeutics Inc (VKTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | 0 | 0.00 | Sell 100.00% | 0.17 | SEC | ||
| 2024 Q3 | 721,926 | 0.17 | Reduce 46.70% | 0.13 | $63.31 | $45,705,135 | SEC |
| 2024 Q2 | 1,354,450 | 0.28 | Add 23.70% | 0.05 | $53.01 | $71,799,395 | SEC |
| 2024 Q1 | 1,094,940 | 0.33 | Reduce 78.72% | 0.28 | $82.00 | $89,785,080 | SEC |
| 2023 Q4 | 5,145,112 | 0.35 | Add 12.50% | 0.04 | $18.61 | $95,750,534 | SEC |
| 2023 Q3 | 4,573,316 | 0.21 | Add 29.03% | 0.05 | $11.07 | $50,626,608 | SEC |
| 2023 Q2 | 3,544,506 | 0.24 | Add 81.30% | 0.11 | $16.21 | $57,456,442 | SEC |
| 2023 Q1 | 1,955,063 | 0.15 | Buy | 0.15 | $16.65 | $32,551,799 | SEC |